REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 8 filers reported holding REGENERON PHARMACEUTICALS in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,813,000 | -64.7% | 9,800 | -72.2% | 0.18% | +83.8% |
| Q1 2017 | $13,640,000 | +66.6% | 35,200 | +57.8% | 0.10% | +160.5% |
| Q4 2016 | $8,186,000 | -24.9% | 22,300 | -17.7% | 0.04% | -26.9% |
| Q3 2016 | $10,895,000 | +98.7% | 27,100 | +72.6% | 0.05% | +100.0% |
| Q2 2016 | $5,483,000 | -11.0% | 15,700 | -8.2% | 0.03% | -13.3% |
| Q1 2016 | $6,164,000 | -60.3% | 17,100 | -40.2% | 0.03% | -60.0% |
| Q4 2015 | $15,526,000 | -53.6% | 28,600 | -60.2% | 0.08% | -46.0% |
| Q3 2015 | $33,444,000 | +120.0% | 71,900 | +141.3% | 0.14% | +104.4% |
| Q2 2015 | $15,202,000 | +28.0% | 29,800 | +13.3% | 0.07% | +25.9% |
| Q1 2015 | $11,874,000 | -38.3% | 26,300 | -43.9% | 0.05% | -29.9% |
| Q4 2014 | $19,241,000 | +15.3% | 46,900 | +1.3% | 0.08% | +11.6% |
| Q3 2014 | $16,692,000 | +74.8% | 46,300 | +37.0% | 0.07% | +60.5% |
| Q2 2014 | $9,547,000 | -33.1% | 33,800 | -28.8% | 0.04% | -28.3% |
| Q1 2014 | $14,263,000 | +13.9% | 47,500 | +4.4% | 0.06% | +33.3% |
| Q4 2013 | $12,523,000 | -44.7% | 45,500 | -37.2% | 0.04% | -43.8% |
| Q3 2013 | $22,652,000 | +66.2% | 72,400 | +19.5% | 0.08% | +60.0% |
| Q2 2013 | $13,628,000 | – | 60,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,198 | $80,686,000 | 4.69% |
| SIMPLEX TRADING, LLC | 1,029 | $1,326,000 | 0.08% |
| Allianz Asset Management GmbH | 205,300 | $75,364,000 | 0.07% |
| Timber Hill LLC | 22,300 | $8,186,000 | 0.04% |